LIVIVO - Suchergebnisse -

Suchergebnis

Treffer 1 - 10 von insgesamt 65

Suchoptionen

Artikel ; Online: The repertoire of CSF antiviral antibodies in patients with neuroinflammatory diseases.

Enose-Akahata, Yoshimi / Wang, Limin / Almsned, Fahad / Johnson, Kory R / Mina, Yair / Ohayon, Joan / Wang, Xin Wei / Jacobson, Steven

Science advances

2023 Band 9, Heft 1, Seite(n) eabq6978

Abstract: Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS). Although various viruses have been proposed to contribute to MS pathology, the etiology of MS remains unknown. Since intrathecal antibody ... ...

Abstract	Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS). Although various viruses have been proposed to contribute to MS pathology, the etiology of MS remains unknown. Since intrathecal antibody synthesis is well documented in chronic viral infection and neuroinflammatory diseases, we hypothesized whether the patterns of antigen-specific antibody responses associated with various viral exposures may define patients with CNS chronic immune dysregulation. The pan-viral antibody profiling in cerebrospinal fluid (CSF) and serum of patients with MS showed significant differences from those in healthy volunteers and a pattern of antibody responses against multiple viruses, including the previously identified Epstein-Barr virus. These findings demonstrate that virus-specific antibody signatures might be able to reflect disease-associated inflammatory milieu in CSF of subjects with neuroinflammatory diseases.
Mesh-Begriff(e)	Humans ; Epstein-Barr Virus Infections ; Herpesvirus 4, Human ; Neuroinflammatory Diseases ; Antiviral Agents ; Multiple Sclerosis
Chemische Substanzen	Antiviral Agents
Sprache	Englisch
Erscheinungsdatum	2023-01-04
Erscheinungsland	United States
Dokumenttyp	Journal Article
ZDB-ID	2810933-8
ISSN	2375-2548 ; 2375-2548
ISSN (online)	2375-2548
ISSN	2375-2548
DOI	10.1126/sciadv.abq6978
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Über subito bestellen

Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

Details ▾
- Kostenpflichtig bestellen

Artikel: Unstable EBV latency drives inflammation in multiple sclerosis patient derived spontaneous B cells.

Soldan, Samantha / Su, Chenhe / Monaco, Maria Chiara / Brown, Natalie / Clauze, Annaliese / Andrada, Frances / Feder, Andries / Planet, Paul / Kossenkov, Andrew / Schäffer, Daniel / Ohayon, Joan / Auslander, Noam / Jacobson, Steve / Lieberman, Paul

Research square

2023

Abstract: Epidemiological studies have demonstrated that Epstein-Barr virus (EBV) is a known etiologic risk factor, and perhaps prerequisite, for the development of MS. EBV establishes life-long latent infection in a subpopulation of memory B cells. Although the ... ...

Abstract	Epidemiological studies have demonstrated that Epstein-Barr virus (EBV) is a known etiologic risk factor, and perhaps prerequisite, for the development of MS. EBV establishes life-long latent infection in a subpopulation of memory B cells. Although the role of memory B cells in the pathobiology of MS is well established, studies characterizing EBV-associated mechanisms of B cell inflammation and disease pathogenesis in EBV (+) B cells from MS patients are limited. Accordingly, we analyzed spontaneous lymphoblastoid cell lines (SLCLs) from multiple sclerosis patients and healthy controls to study host-virus interactions in B cells, in the context of an individual's endogenous EBV. We identify differences in EBV gene expression and regulation of both viral and cellular genes in SLCLs. Our data suggest that EBV latency is dysregulated in MS SLCLs with increased lytic gene expression observed in MS patient B cells, especially those generated from samples obtained during "active" disease. Moreover, we show increased inflammatory gene expression and cytokine production in MS patient SLCLs and demonstrate that tenofovir alafenamide, an antiviral that targets EBV replication, decreases EBV viral loads, EBV lytic gene expression, and EBV-mediated inflammation in both SLCLs and in a mixed lymphocyte assay. Collectively, these data suggest that dysregulation of EBV latency in MS drives a pro-inflammatory, pathogenic phenotype in memory B cells and that this response can be attenuated by suppressing EBV lytic activation. This study provides further support for the development of antiviral agents that target EBV-infection for use in MS.
Sprache	Englisch
Erscheinungsdatum	2023-02-01
Erscheinungsland	United States
Dokumenttyp	Preprint
DOI	10.21203/rs.3.rs-2398872/v1
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Fernleihe an ZB MED

Sie können sich den gewünschten Titel als lokale Nutzerin oder lokaler Nutzer von ZB MED direkt an den Standort Köln schicken lassen.

Details ▾

Artikel ; Online: EBNA1 Inhibitors Block Proliferation of Spontaneous Lymphoblastoid Cell Lines From Patients With Multiple Sclerosis and Healthy Controls.

Monaco, Maria Chiara G / Soldan, Samantha S / Su, Chenhe / Clauze, Annaliese / Cooper, John F / Patel, Rishi J / Lu, Fang / Hughes, Randall J / Messick, Troy E / Andrada, Frances C / Ohayon, Joan / Lieberman, Paul M / Jacobson, Steven

Neurology(R) neuroimmunology & neuroinflammation

2023 Band 10, Heft 5

Abstract: Background and objectives: Epstein-Barr virus (EBV) is a ubiquitous herpesvirus that establishes lifelong latency in memory B cells and has been identified as a major risk factor of multiple sclerosis (MS). B cell depletion therapies have disease- ... ...

Abstract	Background and objectives: Epstein-Barr virus (EBV) is a ubiquitous herpesvirus that establishes lifelong latency in memory B cells and has been identified as a major risk factor of multiple sclerosis (MS). B cell depletion therapies have disease-modifying benefit in MS. However, it is unclear whether this benefit is partly attributable to the elimination of EBV Methods: In this study, we describe the establishment of spontaneous lymphoblastoid cell lines (SLCLs) generated ex vivo with the endogenous EBV of patients with MS and controls and treated with either an Epstein-Barr virus nuclear antigen 1 (EBNA1) inhibitor (VK-1727) or cladribine, a nucleoside analog that eliminates B cells. Results: We showed that a small molecule inhibitor of EBNA1, a critical regulator of the EBV life cycle, blocks the proliferation and metabolic activity of these SLCLs. In contrast to cladribine, a highly cytotoxic B cell depleting therapy currently used in MS, the EBNA1 inhibitor VK-1727 was cytostatic rather than cytotoxic and selective for EBV Discussion: This study shows that patient-derived SLCLs provide a useful tool for interrogating the role of EBV
Mesh-Begriff(e)	Humans ; Cell Line ; Cell Proliferation ; Cladribine/pharmacology ; Epstein-Barr Virus Infections/complications ; Epstein-Barr Virus Infections/drug therapy ; Epstein-Barr Virus Infections/genetics ; Epstein-Barr Virus Nuclear Antigens ; Herpesvirus 4, Human ; Multiple Sclerosis ; Case-Control Studies
Chemische Substanzen	Cladribine (47M74X9YT5) ; Epstein-Barr Virus Nuclear Antigens
Sprache	Englisch
Erscheinungsdatum	2023-08-10
Erscheinungsland	United States
Dokumenttyp	Journal Article ; Research Support, N.I.H., Extramural
ZDB-ID	2767740-0
ISSN	2332-7812 ; 2332-7812
ISSN (online)	2332-7812
ISSN	2332-7812
DOI	10.1212/NXI.0000000000200149
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Über subito bestellen

Details ▾
- Kostenpflichtig bestellen

Artikel ; Online: Effect of Teriflunomide on Cells From Patients With Human T-cell Lymphotropic Virus Type 1-Associated Neurologic Disease.

Enose-Akahata, Yoshimi / Ngouth, Nyater / Ohayon, Joan / Mandel, Matt / Chavin, Jeffrey / Turner, Timothy J / Jacobson, Steven

Neurology(R) neuroimmunology & neuroinflammation

2021 Band 8, Heft 3

Abstract: Objective: To test the hypothesis that teriflunomide can reduce ex vivo spontaneous proliferation of peripheral blood mononuclear cells (PBMCs) from patients with human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic ... ...

Abstract	Objective: To test the hypothesis that teriflunomide can reduce ex vivo spontaneous proliferation of peripheral blood mononuclear cells (PBMCs) from patients with human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Methods: PBMCs from patients with HAM/TSP were cultured in the presence and absence of teriflunomide and assessed for cell viability, lymphocyte proliferation, activation markers, HTLV-1 Results: In culture, teriflunomide did not affect cell viability. A concentration-dependent reduction in spontaneous proliferation of PBMCs was observed with 25 μM (38.3% inhibition), 50 μM (65.8% inhibition), and 100 μM (90.7% inhibition) teriflunomide. The inhibitory effects of teriflunomide were detected in both CD8 Conclusions: These results suggest that teriflunomide inhibits abnormal T-cell proliferation associated with HTLV-1 infection and may have potential as a therapeutic option in patients with HAM/TSP.
Mesh-Begriff(e)	Adult ; Aged ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Crotonates/pharmacology ; Female ; Gene Products, tax/metabolism ; HTLV-I Infections/complications ; Human T-lymphotropic virus 1/genetics ; Humans ; Hydroxybutyrates/pharmacology ; Leukocytes, Mononuclear/drug effects ; Male ; Middle Aged ; Nitriles/pharmacology ; Paraparesis, Tropical Spastic/drug therapy ; Primary Cell Culture ; RNA, Messenger/metabolism ; T-Lymphocyte Subsets/drug effects ; Toluidines/pharmacology
Chemische Substanzen	Crotonates ; Gene Products, tax ; Hydroxybutyrates ; Nitriles ; RNA, Messenger ; Toluidines ; teriflunomide (1C058IKG3B)
Sprache	Englisch
Erscheinungsdatum	2021-04-09
Erscheinungsland	United States
Dokumenttyp	Journal Article ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't
ZDB-ID	2767740-0
ISSN	2332-7812 ; 2332-7812
ISSN (online)	2332-7812
ISSN	2332-7812
DOI	10.1212/NXI.0000000000000986
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Über subito bestellen

Details ▾
- Kostenpflichtig bestellen

Artikel ; Online: Immunopathogenic CSF TCR repertoire signatures in virus-associated neurologic disease.

Nozuma, Satoshi / Enose-Akahata, Yoshimi / Johnson, Kory R / Monaco, Maria Chiara / Ngouth, Nyater / Elkahloun, Abdel / Ohayon, Joan / Zhu, Jun / Jacobson, Steven

JCI insight

2021 Band 6, Heft 4

Abstract: In this study, we examined and characterized disease-specific TCR signatures in cerebrospinal fluid (CSF) of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). TCR β libraries using unique molecular identifier-based ... ...

Abstract	In this study, we examined and characterized disease-specific TCR signatures in cerebrospinal fluid (CSF) of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). TCR β libraries using unique molecular identifier-based methodologies were sequenced in paired peripheral blood mononuclear cells (PBMCs) and CSF cells from HAM/TSP patients and normal healthy donors (NDs). The sequence analysis demonstrated that TCR β repertoires in CSF of HAM/TSP patients were highly expanded and contained both TCR clonotypes shared with PBMCs and uniquely enriched within the CSF. In addition, we analyzed TCR β repertoires of highly expanded and potentially immunopathologic HTLV-1 Tax11-19-specific CD8+ T cells from PBMCs of HLA-A*0201+ HAM/TSP and identified a conserved motif (PGLAG) in the CDR3 region. Importantly, TCR β clonotypes of expanded clones in HTLV-1 Tax11-19-specific CD8+ T cells were also expanded and enriched in the CSF of the same patient. These results suggest that exploring TCR repertoires of CSF and antigen-specific T cells may provide a TCR repertoire signature in virus-associated neurologic disorders.
Mesh-Begriff(e)	CD8-Positive T-Lymphocytes ; Clone Cells ; HTLV-I Infections ; Human T-lymphotropic virus 1 ; Humans ; Leukocytes, Mononuclear ; Nervous System Diseases/immunology ; Nervous System Diseases/virology ; Paraparesis, Tropical Spastic/blood ; Paraparesis, Tropical Spastic/cerebrospinal fluid ; Paraparesis, Tropical Spastic/immunology ; Receptors, Antigen, T-Cell/immunology ; Receptors, Antigen, T-Cell, alpha-beta/blood ; Receptors, Antigen, T-Cell, alpha-beta/immunology
Chemische Substanzen	Receptors, Antigen, T-Cell ; Receptors, Antigen, T-Cell, alpha-beta
Sprache	Englisch
Erscheinungsdatum	2021-02-22
Erscheinungsland	United States
Dokumenttyp	Journal Article ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't
ISSN	2379-3708
ISSN (online)	2379-3708
DOI	10.1172/jci.insight.144869
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Über subito bestellen

Fernleihe an ZB MED

Sie können sich den gewünschten Titel als lokale Nutzerin oder lokaler Nutzer von ZB MED direkt an den Standort Köln schicken lassen.

Details ▾
- Kostenpflichtig bestellen

Artikel ; Online: Multiple sclerosis patient-derived spontaneous B cells have distinct EBV and host gene expression profiles in active disease.

Nature microbiology

2024 Band 9, Heft 6, Seite(n) 1540–1554

Abstract: Epstein-Barr virus (EBV) is an aetiologic risk factor for the development of multiple sclerosis (MS). However, the role of EBV-infected B cells in the immunopathology of MS is not well understood. Here we characterized spontaneous lymphoblastoid cell ... ...

Abstract	Epstein-Barr virus (EBV) is an aetiologic risk factor for the development of multiple sclerosis (MS). However, the role of EBV-infected B cells in the immunopathology of MS is not well understood. Here we characterized spontaneous lymphoblastoid cell lines (SLCLs) isolated from MS patients and healthy controls (HC) ex vivo to study EBV and host gene expression in the context of an individual's endogenous EBV. SLCLs derived from MS patient B cells during active disease had higher EBV lytic gene expression than SLCLs from MS patients with stable disease or HCs. Host gene expression analysis revealed activation of pathways associated with hypercytokinemia and interferon signalling in MS SLCLs and upregulation of forkhead box protein 1 (FOXP1), which contributes to EBV lytic gene expression. We demonstrate that antiviral approaches targeting EBV replication decreased cytokine production and autologous CD4
Mesh-Begriff(e)	Humans ; Herpesvirus 4, Human/genetics ; Multiple Sclerosis/virology ; Multiple Sclerosis/immunology ; Multiple Sclerosis/genetics ; Multiple Sclerosis/metabolism ; B-Lymphocytes/immunology ; B-Lymphocytes/metabolism ; B-Lymphocytes/virology ; Epstein-Barr Virus Infections/virology ; Epstein-Barr Virus Infections/immunology ; Epstein-Barr Virus Infections/genetics ; Epstein-Barr Virus Infections/complications ; Cytokines/metabolism ; CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/virology ; CD4-Positive T-Lymphocytes/metabolism ; Forkhead Transcription Factors/genetics ; Forkhead Transcription Factors/metabolism ; Transcriptome ; Virus Replication ; Gene Expression Regulation, Viral ; Cell Line ; Host-Pathogen Interactions/genetics ; Host-Pathogen Interactions/immunology ; Gene Expression Profiling ; Adult ; Female ; Male
Chemische Substanzen	Cytokines ; Forkhead Transcription Factors
Sprache	Englisch
Erscheinungsdatum	2024-05-28
Erscheinungsland	England
Dokumenttyp	Journal Article
ISSN	2058-5276
ISSN (online)	2058-5276
DOI	10.1038/s41564-024-01699-6
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Über subito bestellen

Fernleihe an ZB MED

Sie können sich den gewünschten Titel als lokale Nutzerin oder lokaler Nutzer von ZB MED direkt an den Standort Köln schicken lassen.

Details ▾
- Kostenpflichtig bestellen

Artikel ; Online: Viral Immune signatures from cerebrospinal fluid extracellular vesicles and particles in HAM and other chronic neurological diseases.

Pleet, Michelle L / Welsh, Joshua A / Stack, Emily H / Cook, Sean / Johnson, Dove-Anna / Killingsworth, Bryce / Traynor, Tim / Clauze, Annaliese / Hughes, Randall / Monaco, Maria Chiara / Ngouth, Nyater / Ohayon, Joan / Enose-Akahata, Yoshimi / Nath, Avindra / Cortese, Irene / Reich, Daniel S / Jones, Jennifer C / Jacobson, Steven

Frontiers in immunology

2023 Band 14, Seite(n) 1235791

Abstract: Background and objectives: Extracellular vesicles and particles (EVPs) are released from virtually all cell types, and may package many inflammatory factors and, in the case of infection, viral components. As such, EVPs can play not only a direct role ... ...

Abstract	Background and objectives: Extracellular vesicles and particles (EVPs) are released from virtually all cell types, and may package many inflammatory factors and, in the case of infection, viral components. As such, EVPs can play not only a direct role in the development and progression of disease but can also be used as biomarkers. Here, we characterized immune signatures of EVPs from the cerebrospinal fluid (CSF) of individuals with HTLV-1-associated myelopathy (HAM), other chronic neurologic diseases, and healthy volunteers (HVs) to determine potential indicators of viral involvement and mechanisms of disease. Methods: We analyzed the EVPs from the CSF of HVs, individuals with HAM, HTLV-1-infected asymptomatic carriers (ACs), and from patients with a variety of chronic neurologic diseases of both known viral and non-viral etiologies to investigate the surface repertoires of CSF EVPs during disease. Results: Significant increases in CD8+ and CD2+ EVPs were found in HAM patient CSF samples compared to other clinical groups ( Discussion: These data suggest that CD8+ and CD2+ CSF EVPs may be important as: 1) potential biomarkers and indicators of disease pathways for viral-mediated neurological diseases, particularly HAM, and 2) as possible meditators of the disease process in infected individuals.
Mesh-Begriff(e)	Humans ; Paraparesis, Tropical Spastic ; Central Nervous System ; Extracellular Vesicles ; Nervous System Diseases ; CD40 Antigens ; Chronic Disease
Chemische Substanzen	CD40 Antigens
Sprache	Englisch
Erscheinungsdatum	2023-08-09
Erscheinungsland	Switzerland
Dokumenttyp	Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Intramural
ZDB-ID	2606827-8
ISSN	1664-3224 ; 1664-3224
ISSN (online)	1664-3224
ISSN	1664-3224
DOI	10.3389/fimmu.2023.1235791
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Über subito bestellen

Details ▾
- Kostenpflichtig bestellen

Artikel ; Online: Central Vein Sign Profile of Newly Developing Lesions in Multiple Sclerosis: A 3-Year Longitudinal Study.

Al-Louzi, Omar / Letchuman, Vijay / Manukyan, Sargis / Beck, Erin S / Roy, Snehashis / Ohayon, Joan / Pham, Dzung L / Cortese, Irene / Sati, Pascal / Reich, Daniel S

Neurology(R) neuroimmunology & neuroinflammation

2022 Band 9, Heft 2

Abstract: Background and objectives: The central vein sign (CVS), a central linear hypointensity within lesions on T2*-weighted imaging, has been established as a sensitive and specific biomarker for the diagnosis of multiple sclerosis (MS). However, the CVS has ... ...

Abstract	Background and objectives: The central vein sign (CVS), a central linear hypointensity within lesions on T2-weighted imaging, has been established as a sensitive and specific biomarker for the diagnosis of multiple sclerosis (MS). However, the CVS has not yet been comprehensively studied in newly developing MS lesions. We aimed to identify the CVS profiles of new white matter lesions in patients with MS followed over time and investigate demographic and clinical risk factors associated with new CVS+ or CVS- lesion development. Methods:* In this retrospective longitudinal cohort study, adults from the NIH MS Natural History Study were considered for inclusion. Participants with new T2 or enhancing lesions were identified through review of the radiology report and/or longitudinal subtraction imaging. Each new lesion was evaluated for the CVS. Clinical characteristics were identified through chart review. Results: A total of 153 adults (95 relapsing-remitting MS, 27 secondary progressive MS, 16 primary progressive MS, 5 clinically isolated syndrome, and 10 healthy; 67% female) were included. Of this cohort, 96 had at least 1 new T2 or contrast-enhancing lesion during median 3.1 years (Q1-Q3: 0.7-6.3) of follow-up; lesions eligible for CVS evaluation were found in 62 (65%). Of 233 new CVS-eligible lesions, 159 (68%) were CVS+, with 30 (48%) individuals having only CVS+, 12 (19%) only CVS-, and 20 (32%) both CVS+ and CVS- lesions. In gadolinium-enhancing (Gd+) lesions, the CVS+ percentage increased from 102/152 (67%) at the first time point where the lesion was observed, to 92/114 (82%) after a median follow-up of 2.8 years. Younger age (OR = 0.5 per 10-year increase, 95% CI = 0.3-0.8) and higher CVS+ percentage at baseline (OR = 1.4 per 10% increase, 95% CI = 1.1-1.9) were associated with increased likelihood of new CVS+ lesion development. Discussion: In a cohort of adults with MS followed over a median duration of 3 years, most newly developing T2 or enhancing lesions were CVS+ (68%), and nearly half (48%) developed new CVS+ lesions only. Importantly, the effects of edema and T2 signal changes can obscure small veins in Gd+ lesions; therefore, caution and follow-up is necessary when determining their CVS status. Trial registration information: Clinical trial registration number NCT00001248. Classification of evidence: This study provides Class III evidence that younger age and higher CVS+ percentage at baseline are associated with new CVS+ lesion development.
Mesh-Begriff(e)	Adult ; Cerebral Veins/diagnostic imaging ; Cerebral Veins/pathology ; Disease Progression ; Female ; Humans ; Longitudinal Studies ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Multiple Sclerosis/diagnostic imaging ; Multiple Sclerosis/pathology ; Retrospective Studies ; White Matter/blood supply ; White Matter/diagnostic imaging ; White Matter/pathology
Sprache	Englisch
Erscheinungsdatum	2022-01-13
Erscheinungsland	United States
Dokumenttyp	Clinical Trial ; Journal Article ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't
ZDB-ID	2767740-0
ISSN	2332-7812 ; 2332-7812
ISSN (online)	2332-7812
ISSN	2332-7812
DOI	10.1212/NXI.0000000000001120
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Über subito bestellen

Details ▾
- Kostenpflichtig bestellen

Artikel ; Online: Comprehensive Analysis of TCR-β Repertoire in Patients with Neurological Immune-mediated Disorders.

Alves Sousa, Alessandra de Paula / Johnson, Kory R / Ohayon, Joan / Zhu, Jun / Muraro, Paolo A / Jacobson, Steven

Scientific reports

2019 Band 9, Heft 1, Seite(n) 344

Abstract: In this study we characterized the TCR repertoire profiles in patients with chronic progressive inflammatory neurological disorders including HAM/TSP, associated with human T-cell lymphotropic virus type I (HTLV-I) infection, and multiple sclerosis (MS), ...

Abstract	In this study we characterized the TCR repertoire profiles in patients with chronic progressive inflammatory neurological disorders including HAM/TSP, associated with human T-cell lymphotropic virus type I (HTLV-I) infection, and multiple sclerosis (MS), an inflammatory, demyelinating disease of the CNS of unknown etiology. We hypothesized that a T-cell receptor (TCR) clonal repertoire 'signature' could distinguish HAM/TSP patients from healthy controls, as well as from patients with a more heterogeneous CNS-reactive inflammatory disease such as MS. In this study, we applied an unbiased molecular technique - unique molecular identifier (UMI) library-based strategy to investigate with high accuracy the TCR clonal repertoire by high throughput sequencing (HTS) technology. cDNA-TCR β-chain libraries were sequenced from 2 million peripheral mononuclear cells (PBMCs) in 14 HAM/TSP patients, 34 MS patients and 20 healthy controls (HC). While HAM/TSP patients showed a higher clonal T-cell expansion compared to MS and HC, increase of the TCR clonal expansion was inversely correlated with the diversity of TCR repertoire in all subjects. In addition, longitudinal analysis of TCR repertoires from HAM/TSP patients demonstrated a correlation of the TCR clonal expansion with HTLV-I proviral load. Surprisingly, MS patients showed a higher diversity of TCR repertoires than other groups. Despite higher TCR clonal expansions in HAM/TSP patients, no disease-specific TCRs were shared among patients. Only non-shared or "private" TCR repertoires was observed. While no clones that shared the same CDR3 amino acid sequences were seen in either HC or MS patients, there was a cluster of related CDR3 amino acid sequences observed for 18 out of 34 MS patients when evaluated by phylogenetic tree analysis. This suggests that a TCR-repertoire signature may be identified in a subset of patients with MS.
Mesh-Begriff(e)	Adult ; Aged ; Female ; Genetic Variation ; HTLV-I Infections/pathology ; Humans ; Leukocytes, Mononuclear/pathology ; Longitudinal Studies ; Male ; Middle Aged ; Multiple Sclerosis/pathology ; Receptors, Antigen, T-Cell, alpha-beta/genetics ; Sequence Analysis, DNA ; Time Factors ; Viral Load ; Young Adult
Chemische Substanzen	Receptors, Antigen, T-Cell, alpha-beta
Sprache	Englisch
Erscheinungsdatum	2019-01-23
Erscheinungsland	England
Dokumenttyp	Journal Article ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't
ZDB-ID	2615211-3
ISSN	2045-2322 ; 2045-2322
ISSN (online)	2045-2322
ISSN	2045-2322
DOI	10.1038/s41598-018-36274-7
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Über subito bestellen

Details ▾
- Kostenpflichtig bestellen

Artikel ; Online: Lesion size and shape in central vein sign assessment for multiple sclerosis diagnosis: An in vivo and postmortem MRI study.

Al-Louzi, Omar / Manukyan, Sargis / Donadieu, Maxime / Absinta, Martina / Letchuman, Vijay / Calabresi, Brent / Desai, Parth / Beck, Erin S / Roy, Snehashis / Ohayon, Joan / Pham, Dzung L / Thomas, Anish / Jacobson, Steven / Cortese, Irene / Auluck, Pavan K / Nair, Govind / Sati, Pascal / Reich, Daniel S

Multiple sclerosis (Houndmills, Basingstoke, England)

2022 Band 28, Heft 12, Seite(n) 1891–1902

Abstract: Background: The "central vein sign" (CVS), a linear hypointensity on T2*-weighted imaging corresponding to a central vein/venule, is associated with multiple sclerosis (MS) lesions. The effect of lesion-size exclusion criteria on MS diagnostic accuracy ... ...

Abstract	Background: The "central vein sign" (CVS), a linear hypointensity on T2-weighted imaging corresponding to a central vein/venule, is associated with multiple sclerosis (MS) lesions. The effect of lesion-size exclusion criteria on MS diagnostic accuracy has not been extensively studied. Objective:* Investigate the optimal lesion-size exclusion criteria for CVS use in MS diagnosis. Methods: Cross-sectional study of 163 MS and 51 non-MS, and radiological/histopathological correlation of 5 MS and 1 control autopsy cases. The effects of lesion-size exclusion on MS diagnosis using the CVS, and intralesional vein detection on histopathology were evaluated. Results: CVS+ lesions were larger compared to CVS- lesions, with effect modification by MS diagnosis (mean difference +7.7 mm Conclusion: Lesion-size measures add important information when using CVS+ lesion counts for MS diagnosis. The CVS is a specific biomarker corresponding to intralesional veins on histopathology.
Mesh-Begriff(e)	Brain/pathology ; Cross-Sectional Studies ; Humans ; Magnetic Resonance Imaging/methods ; Multiple Sclerosis/pathology ; Veins/diagnostic imaging
Sprache	Englisch
Erscheinungsdatum	2022-06-08
Erscheinungsland	England
Dokumenttyp	Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Intramural ; Research Support, N.I.H., Extramural
ZDB-ID	1290669-4
ISSN	1477-0970 ; 1352-4585
ISSN (online)	1477-0970
ISSN	1352-4585
DOI	10.1177/13524585221097560
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Verfügbar in ZB MED Köln/Königswinter

Zs.A 4428: Hefte anzeigen

Standort:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Über subito bestellen

Details ▾
- Im ZB MED-Bestand
- Kostenpflichtig bestellen

Zum Seitenanfang

Zusatzmaterialien

Kategorien

Über subito bestellen

Zusatzmaterialien

Kategorien

Fernleihe an ZB MED

Zusatzmaterialien

Kategorien

Über subito bestellen

Zusatzmaterialien

Kategorien

Über subito bestellen

Zusatzmaterialien

Kategorien

Über subito bestellen

Fernleihe an ZB MED

Zusatzmaterialien

Kategorien

Über subito bestellen

Fernleihe an ZB MED

Zusatzmaterialien

Kategorien

Über subito bestellen

Zusatzmaterialien

Kategorien

Über subito bestellen

Zusatzmaterialien

Kategorien

Über subito bestellen

Zusatzmaterialien

Kategorien

Verfügbar in ZB MED Köln/Königswinter

Über subito bestellen